Quetiapine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Quetiapine. Educational only — not medical advice.

Reported adverse reactions

ReactionHighest frequency reported*
Headache21%
Agitation20%
Somnolence18%
Extrapyramidal symptoms12.9%
Dizziness11%
Fatigue10%
Nausea10%
Dry mouth9%
Constipation8%
Tremor8%
Dystonic event7.8%
Parkinsonism7.8%
Other extrapyramidal event7.8%
Pain7%
Tachycardia6%
Vomiting6%
Asthenia5%
Dyspepsia5%
Weight gain5%
Alt increased5%

*Highest percentage across placebo-controlled trial tables summarized in current labeling.

Labeled uses

1.1 Schizophrenia Quetiapine tablets, USP are indicated for the treatment of schizophrenia. The efficacy of Quetiapine tablets, USP in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents (13-17 years). The effectiveness of Quetiapine tablets, USP for the maintenance treatment of schizophrenia has not been systematically evaluated in controlled clinical trials [see Clinical Studies (14.1)]. 1.2 Bipolar Disorder Quetiapine tablets, USP are indicated for the acute treatment of manic episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex. Efficacy was established in two 12-week monotherapy trials in adults, in one 3-week adjunctive trial in adults, and in one 3-week monotherapy trial in pediatric patients (10-17 years) [see Clinical Studies (14.2)]. Quetiapine tablets, USP are indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder. Efficacy was established in two 8-week monotherapy trials in adult patients with bipolar I and bipolar II disorder [see Clinical Studies (14.2)]. Quetiapine tablets, USP are indicated for the maintenance treatm…

Source: FDA labeling via NIH DailyMed (set d323b6c0…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.